Abbonarsi

Cardiac MRI prediction of recovery in children with acute myocarditis - 14/08/21

Doi : 10.1016/j.acvdsp.2021.06.007 
Lamia Ait-Ali, Duarte S. Martins , Diala Khraiche, Pierluigi Festa, Andrea Barison, Nicola Martini, Yasmine Benadjaoud, Rui Anjos, Nathalie Boddaert, Damien Bonnet, Giovanni D. Aquaro, Francesca Raimondi
 Pediatric Cardiology Department, Hospital de Santa Cruz CHLO EPE, avenue Professor Doutor Reinaldo dos Santos, 2794-035 Carnaxidem, Portugal 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Riassunto

Myocarditis, defined as inflammation of myocardial tissue, is a rare disease in the pediatric population. Cardiovascular cardiac magnetic resonance (CMR) is a powerful tool for noninvasive assessment of myocardial inflammation as defined by the Lake Louise criteria, with a sensitivity of approximately 82% [1]. CMR allows tissue characterization of the myocardium, as well as accurate definition of ventricular volumes and function. Few prognostic factors have been associated with either normalization of function or progression to dilated cardiomyopathy in pediatric myocarditis. In the present study, we aimed to describe CMR findings in a large cohort of pediatric patients with acute myocarditis and to assess disease evolution. Our study received the proper ethical oversight [CNIL (Commission nationale de l’informatique et des libertés) declaration 2130271 v 0]. Sixty-eight children younger than 18 years of age with clinical myocarditis and positive acute-phase myocardial inflammation, as defined by the Lake Louise criteria [2], underwent follow-up CMR during a 12-year period (from March 2007 to March 2019). The first follow-up CMR study was performed at a median of 5 months after the first examination (interquartile range: 1 to 6 months), and additional CMR studies were performed in 47% of the cohort (32 patients). Patient characteristics are presented in Table 1. Most of the cohort were males (73.5%) who presented with chest pain (68%) or new-onset heart failure (33%). Fever was found in 55% of the cohort. Full recovery from acute myocarditis, as defined by normalization of ventricular function [left ventricular ejection fraction (LVEF) >55%, right ventricular EF >54%], ventricular dimensions (LV end-diastolic volume index <104ml/m2 for males, <95ml/m2 for females, right ventricular end-diastolic volume index <108ml/m2 for males, <94ml/m2 females), regional wall function and tissue abnormalities [absent myocardial edema and late gadolinium enhancement (LGE)], was observed in 26% of the cohort (n ¼ 18). Fever at presentation was significantly more common in the patients who had full recovery (100% vs. 43%; P<0.01). Although baseline LV function was not different between those who had full recovery and those who did not, a non-significantly larger LV volume (79ml/m2 vs. 89ml/m2) was found in those who did not recover. Concerning tissue characterization parameters, positive T2 (90% vs. 77%) and LGE (96% vs. 83%) were significantly more common in patients who did not recover. Early gadolinium enhancement followed the same pattern, without statistical significance. The prevalence of a sub-epicardial pattern of LGE was not different between groups (P ¼ 0.11), but other LGE patterns were more frequent in patients who did not recover (P ¼ 0.04). Conversely, acute-phase LGE extent did not differ between groups (4% vs. 3.9%; P ¼ 0.85). To the best of our knowledge, this was the largest multicenter pediatric study that assessed repeated CMR evaluation of acute myocarditis. In the present study, we confirmed the recent finding that LGE in the acute phase of myocarditis was not necessarily a marker of fibrosis. In our population, LGE disappeared completely in 26% of patients, which was higher than the 10% reported in adults [3]. This difference might translate to a higher healing ability of pediatric patients from tissue damage, as seen in other medical conditions. This complete healing of myocardial tissue abnormalities might be clinically relevant because residual fibrosis was associated with worse prognosis independently of LVEF [3, 4]. In our study, an LGE pattern other than sub-epicardial was associated with non-recovery. This result was concordant with a recent study by Aquaro et al. [5], who demonstrated a worse prognosis in association with a mid-wall septal pattern of LGE compared with a sub-epicardial inferior-lateral pattern.

In conclusion, we found that fever at presentation was associated with full recovery from acute myocarditis, whereas specific acute-phase CMR findings (positive T2 criteria, LGE presence, and patterns other than sub-epicardial) were associated with its absence.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Due to the pandemic, this abstract was already published in JACC: Cardiovascular Imaging, https://doi.org/10.1016/j.jcmg.2020.08.033.


© 2021  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 13 - N° 4

P. 272-273 - Settembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Long-term follow-up of patients with tetralogy of fallot and implantable cardioverter defibrillator–The DAI-T4F nationwide registry
  • Victor Waldmann, Abdeslam Bouzeman, Guillaume Duthoit, Linda Koutbi, Francis Bessiere, Fabien Labombarda, Christelle Marquié, Jean Baptiste Gourraud, Pierre Mondoly, Jean-Marc Sellal, Pierre Bordachar, Alexis Hermida, Frédéric Anselme, Anouk Asselin, Caroline Audinet, Yvette Bernard, Paul Bru, Sok Sithikun Bun, Gael Clerici, Antoine Da Costa, Maxime de Guillebon, Pascal Defaye, Nathalie Elbaz, Romain Eschalier, Rodrigue Garcia, Charles Guenancia, Benoit Guy-Moyat, Franck Halimi, Didier Irles, Laurence Iserin, François Jourda, Magalie Ladouceur, Philippe Lagrange, Mikael Laredo, Jacques Mansourati, Grégoire Massoulié, Amel Mathiron, Philippe Maury, Anne Messali, Kumar Narayanan, Cédric Nguyen, Sandro Ninni, Marie-Cécile Perier, Bertrand Pierre, Penelope Pujadas, Frédéric Sacher, Pascal Sagnol, Ardalan Sharifzadehgan, Camille Walton, Pierre Winum, Cyril Zakine, Laurent Fauchier, Raphael Martins, Jean-Luc Pasquié, Jean-Benoit Thambo, Xavier Jouven, Nicolas Combes, Eloi Marijon, DAI-T4F investigators
| Articolo seguente Articolo seguente
  • Transplantation for Pulmonary Arterial Hypertension with Congenital Heart Disease: Impact of current therapeutic approach including a high-priority allocation programme on outcomes
  • Sébastien Hascoët, Margaux Pontailler, Jérôme Le Pavec, Laurent Savale, Olaf Mercier, Dominique Fabre, Sacha Mussot, Gérald Simonneau, Xavier Jais, Séverine Feuillet, Francois Stephan, Sarah Cohen, Damien Bonnet, Marc Humbert, Philippe Dartevelle, Elie Fadel

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.